Inspire Medical Systems, Inc.: Expansion in International Markets & 3 Factors Driving Our ‘Buy’ Rating! 

Inspired Medical Systems First Quarter 2024 performance showcases a robust growth trajectory alongside strategic market advancements and impending innovations. The company reported a notable increase in revenue, which reached $164 million, marking a 28% year-over-year growth. This uplift was primarily driven by enhanced penetration in existing markets and expansion into new territories, both domestically and internationally. U.S. revenue climbed to $155.8 million, showing a 25% increase, underpinned by a rising number of implanting centers and sales territories. Notably, international revenue, particularly from Europe, witnessed a significant surge of 141%, totaling $8.2 million—reflective of a strong recovery in Germany following recent regulatory approvals.